Dow Up 0.04% Nasdaq Up 0.89%

Isis Pharmaceuticals, Inc. (ISIS)

-NasdaqGS
52.42 Up 1.48(2.91%) 4:00PM EST
|After Hours : 52.40 Down 0.02 (0.04%) 7:55PM EST
Prev Close:50.94
Open:51.08
Bid:N/A
Ask:69.79 x 100
1y Target Est:49.20
Beta:1.72
Next Earnings Date:N/A
Day's Range:51.05 - 52.45
52wk Range:22.25 - 62.66
Volume:1,225,943
Avg Vol (3m):2,405,200
Market Cap:6.19B
P/E (ttm):N/A
EPS (ttm):-0.81
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ISIS

Comparison

Symbol% ChgMkt Cap
ISISUp 2.91%6.19B
ENZUp 5.13%209.61M
GILDUp 0.02%151.77B
SRPTUp 5.59%686.14M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):35.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.65
Quarterly EPS Est (Dec-14) :-0.06
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-3.45

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback